"University Clinical Investigators is dedicated to performing high quality clinical trials to evaluate investigational medications, in Orange County CA"

During the past decade, University Clinical Investigators, Inc. conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 31 clinical trials were completed, i.e. on average, 93.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 19 clinical trials were completed. i.e. 126.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Clinical Investigators, Inc." #1 sponsor was "Eli Lilly and Company" with 21 trials, followed by "Pfizer" with 5 trials sponsored, "Mannkind Corporation" with 4 trials sponsored, "AstraZeneca" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinical Investigators, Inc." #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Clinquest, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Ergomed" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "University Clinical Investigators, Inc." are "Type 2 Diabetes" (12 trials), "Type 2 Diabetes Mellitus" (7 trials), "Obesity" (5 trials), "Diabetes Mellitus, Type 2" (4 trials) and "Overweight" (3 trials). Many other conditions were trialed in "University Clinical Investigators, Inc." in a lesser frequency.

Most popular intervention types in "University Clinical Investigators, Inc." are "Drug" (40 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Tirzepatide" (8 trials), "Insulin Degludec" (6 trials), "Insulin Glargine" (6 trials) and "Dulaglutide" (4 trials). Other intervention names were less common.

The vast majority of trials in "University Clinical Investigators, Inc." are 42 trials for "All" genders.

Currently, there are NaN active trials in "University Clinical Investigators, Inc.". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in University Clinical Investigators, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University Clinical Investigators, Inc., 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".